Clinical Trials Directory

Trials / Terminated

TerminatedNCT02245074

Non Invasive Evaluation of Bronchial Inflammation in Infants : a Study of the Sputum Cellularity After Hypertonic Saline Induction

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
6 Months – 3 Years
Healthy volunteers
Not accepted

Summary

* Background: Infantile asthma is composed of various phenotypes, however the definition is still based on the clinics. Namely, the infants could be classified as transitory, peristent or late and persistent asthma. Some risk factors for the persistent asthma phenotype are recognized as atopy. However all peristent asthma are not related to atopy. Regarding the pathophysiology, little is known on airways inflammation in these infants, and the current data are mostly based on the BAL analyses, or on biopsies. Consequently, BLA and biopsies should be justified by the need of an indicated fiberbronchoscopy, and therefore limited to severe infantile asthma. Airway secretion could be also collected after hypertonic saline induction and chest physiotherapy. This method has been validated in the children, but has not in the younger. * Aim : Analyses of cell profiles regarding the severity of infantile asthma. * Methods : This descriptive study compared 3 groups of infants, the first with acute exacerbation, the second with uncontrolled asthma and the third with controlled asthma. Accounting 25% of failure, the number of 40 infants per groups has been calculated. The sputum induction will be performed by repeated nebulizations of 3% saline hypertonic solution. Cellularity and cell profiles were analysed as previously recommended. Safety will be evaluated. * Inclusion criteria : Any infants suffering of infantile asthma (at least 3 episodes of wheezing during the 2 first years of life), aged between 6-12months.Asthma control was evaluated on the last 4 weeks, allowing to classify the infants . Control asthma was aimed when neither exacerbation nor persistent symptoms were observed. Uncontrolled asthma was defined whether the infant presented any symptoms during the last 4 weeks. Exacerbation was defined as any acute symptoms, as cough, dyspnoea or wheezing. * Feasibility : A preliminary study has been presented in the Vienna ERS congress.

Conditions

Interventions

TypeNameDescription
OTHERSputum inductionThe sputum induction will be performed by repeated nebulizations of 3% saline hypertonic solution. Cellularity and cell profiles were analysed as previously recommended.

Timeline

Start date
2010-06-01
Primary completion
2012-06-01
Completion
2012-08-01
First posted
2014-09-19
Last updated
2014-09-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02245074. Inclusion in this directory is not an endorsement.